Abstract
Two different froms of hypermotility produced by the amphetamine derivatives PCA and H 77/77, 5 mg/kg of each, was studied in rats treated s.c. with the new 5-HT-uptake inhibitor paroxetine. The substance inhibited the effect of PCA but did not influence that of H 77/77.
The 5-HT-uptake inhibitors paroxetine, imipramine, and chlorimipramine were also administered p.o. at various times before PCA. The three substances inhibited PCA-induced hypermotility. Paroxetine 0.5–2 mg/kg, was active at intervals of 1–4 h and 4 mg/kg was active at 18-h interval. Imipramine and chlorimipramine 25–30 mg/kg showed PCA inhibition at treatment intervals of 1–2 h, but 80–100 mg/kg or more was required to inhibit PCA at intervals of 4 and 18 h.
Previous results have shown that PCA-induced hypermotility is antagonized by substances inhibiting 5-HT synthesis and uptake, whereas H 77/77-induced hypermotility is inhibited by substances blocking NA synthesis, uptake, and receptors.
The previous and present results indicate that paroxetine is a selective 5-HT-uptake inhibitor. After oral administration paroxetine presumably produces a more potent and long-lasting 5-HT-uptake inhibition than imipramine and chlorimipramine.
Similar content being viewed by others
References
Andén, N.-E., Fuxe, K., Henning, M.: Mechanisms of noradrenaline and 5-hydroxytryptamine disappearance induced by α-methyl-Dopa and α-methyl-metatyrosine. Eur. J. Pharmacol. 8, 302–309 (1969)
Buus Lassen, J.: The effect of p-chloroamphetamine on motility in rats after inhibition of monoamine synthesis, storage, uptake and receptor interaction. Psychopharmacologia (Berl.) 34, 243–254 (1974a)
Buus Lassen, J.: Evidence for a noradrenergic and dopaminergic mechanism in the hyperactivity produced by 4,α-dimethyl-m-tyramine (H 77/77) in rats. Psychopharmacologia (Berl.) 37, 331–340 (1974b)
Buus Lassen, J., Petersen, E., Kjellberg, B., Olsson, S. O.: Comparative studies of a new 5HT-uptake inhibitor and some tricyclic thymoleptics. Eur. J. Pharmacol. 32, 108–115 (1975a)
Buus Lassen, J., Squires, R. F., Christensen, J. A., Molander, L.: Neurochemical and pharmacological studies on a new 5HT-uptake inhibitor, FG 4963, with potential, antidepressant properties. Psychopharmacologia (Berl.) 42, 21–26 (1975b)
Buus Lassen, J.: Evidence for a noradrenergic mechanism in the grooming produced by (+)-amphetamine and 4,α-dimethyl-m-tyramine (H 77/77) in rats. Psychopharmacology 54, 153–157 (1977)
Buus Lassen, J.: Potent and long-lasting potentiation of two 5-hydroxytryptophan-induced effects in mice by three selective 5-HT uptake inhibitors. Eur. J. Pharmacol. 47, 351–358 (1978)
Carlsson, A.: Structural specificity for inhibition of (14C)-5-hydroxytryptamine uptake by cerebral slices. J. Pharm. Pharmacol. 22, 729–732 (1970)
Carlsson, A., Corrodi, H., Fuxe, K., Hökfelt, T.: Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,α-dimethyl-meta-tyramine. Eur. J. Pharmacol. 5, 367–373 (1969a)
Carlsson, A., Corrodi, H., Fuxe, K., Hökfelt, T.: Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-metatyramine. Eur. J. Pharmacol. 5, 357–366 (1969b)
Carlsson, A., Jonason, J., Lindqvist, M., Fuxe, K.: Demonstration of extraneuronal 5-hydroxytryptamine accumulation in brain following membrane-pump blockade by chlorimipramine. Brain Res. 12, 456–460 (1969c)
Carlsson, A., Lindqvist, M., Wysokowski, J., Corrodi, H., Junggren, U.: Substituted metatyramines as brain monoamine depletors. Acta Pharm. Suecica 7, 293–302 (1970)
Fuller, R. W., Perry, K. W., Molloy, B. B.: Effect of 3-(p-trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine. J. Pharmacol. Exp. Ther. 193, 796–803 (1975)
Nagy, A.: Blood and brain concentrations of imipramine, clomipramine and their monomethylated metabolites after oral and intramuscular administration in rats. J. Pharm. Pharmacol. 29, 104–107 (1977)
Petersen, E. N., Olsson, S.-O., Squires, R. F.: Effects of 5HT uptake inhibitors on the pressor response to 5HT in the pithed rat. The significance of the 5HT blocking property. Eur. J. Pharmacol. 43, 209–215 (1977)
Ross, S. B., Renyi, A. L.: Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3H-noradrenaline and 14C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain. Acta Pharmacol. Toxicol. 36, 382–394 (1975a)
Ross, S. B., Renyi, A. L.: Tricyclic antidepressant agents. II. Effect of oral administration on the uptake of 3H-noradrenaline and 14C-5-hydroxytryptamine in slices of the midbrain-hypothalamus region of the rat. Acta Pharmacol. Toxicol. 36, 395–408 (1975b)
Ross, S. B.: Antagonism of the acute and long-term biochemical effects of 4-chloroamphetamine on the 5-HT neurones in the rat brain by inhibitors of the 5-hydroxytryptamine uptake. Acta Pharmacol. Toxicol. 39, 456–476 (1976)
Squires, R. F.: Antagonism of p-chloroamphetamine (PCA) induced depletion of 5-HT from rat brain by some thymoleptics and other psychotropic drugs. Acta Pharmacol. (Kbh.) [Suppl. I] 31, 35 (1972)
Squires, R. F.: Effects of noradrenaline pump blockers on its uptake by synaptosomes from several brain regions; additional evidence for dopamine terminals in the frontal cortex. J. Pharm. Pharmacol. 26, 364–367 (1974)
Sugrue, M. F., Goodlet, I., Mireylees, S. E.: On the selective inhibition of serotonin uptake in vivo by ORG 6582. Eur. J. Pharmacol. 40, 121–130 (1976)
Svensson, T. H., Thieme, G.: An investigation of a new instrument to measure motor activity of small animals. Psychopharmacologia (Berl.) 14, 157–163 (1969)
Wong, D. T., Horng, J.-S., Fuller, R. W.: Kinetics of serotonin accumulation into synaptosomes of rat brain-effects of amphetamine and chloroamphetamines. Biochem. Pharmacol. 22, 311–322 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lassen, J.B. Influence of the new 5-HT-uptake inhibitor paroxetine on hypermotility in rats produced by p-chloroamphetamine (PCA) and 4,α-dimethyl-m-tyramine (H 77/77). Psychopharmacology 57, 151–153 (1978). https://doi.org/10.1007/BF00426880
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00426880